PPARG and Cerebral ischemia: We have demonstrated previously [23,24] that the PPARγ agonist, rosiglitazone enhances UCP2 expression in the hippocampal neurons, leading to protection against oxidative stress and neuronal cell death associated with cerebral ischemia.